← Open Payments lookup

LAUREN DEAL: Open Payments

NPI 1932824307 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,340 in 65 payments from 17 companies in 2025. Trend: 2023 $365 · 2024 $638 · 2025 $1,340

Food & beverage: $1,340
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.10$205
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$158
Axsome Therapeutics, Inc.7$144
ABBVIE INC.5$103
Supernus Pharmaceuticals, Inc.5$102
Alkermes, Inc.5$102
Vanda Pharmaceuticals Inc.3$88
Neurocrine BioSciences, Inc.4$87
E.R. Squibb & Sons, L.L.C.3$71
IDORSIA PHARMACEUTICALS US INC3$65

Products named: CAPLYTA, Auvelity, UZEDY, VRAYLAR, Qelbree, ARISTADA, REXULTI, INGREZZA.

Industry payments across MD — which companies pay providers there.